U.S. Medical Equipment Stock News

Figma stock just gave investors a hard reset, sliding about 15% today after a strong recent run. The immediate reaction is all about that price drop. The real story sits in the numbers. Q2 revenue reached about US$370m and net dollar retention of 136% underlines how existing customers keep spending more. Short term traders are fixated on the red screen. Long term holders will likely focus on a design and AI platform that just reported its third consecutive quarter of faster growth and now...

Tennant came into this print as a high P/E industrial stock with a premium reputation and a share price that had already been drifting down in recent months. The market did not wait for nuance. The stock dropped about 12% to US$76.90 after Q2 numbers showed that the real story this quarter was profit pressure, not demand. Revenue in Tennant’s floor cleaning equipment business held at US$324m, yet net income fell to US$7.6m and adjusted earnings per share slid to US$0.83. For a company priced...

Wix.com (NasdaqGS: WIX) and Thryv announced plans for a new partnership to combine AI-driven commerce, payments, and website tools for small and medium businesses. The agreement aims to connect Wix.com's platform with Thryv's existing customer base and direct sales force that focuses on service-based SMBs. Both companies plan to offer an integrated solution that brings together online booking, payments, websites, and automation under a single workflow. Investors are watching how this...

Beyond Meat stock dropped about 14% today, yet the latest quarter shows a company that just posted a profit and is trying to claw its way back from the edge. The disconnect is stark. You have a plant based meat pioneer trading around US$0.53 a share, with trailing earnings in the black and a P/E that screens as very low against food peers, yet the market continues to punish it. The headline this quarter is simple. Revenue of US$68.8m and positive earnings land against a backdrop of weak cash...

KORU Medical Systems just watched its stock slide 13.8% in a single session, even as the business finally put a small profit on the board. That clash between price and progress is the real story today. Coming into this report, the stock had already been under pressure over 7 days and 30 days. Yet KORU delivered record Q2 revenue of US$12.0m and turned a modest net income of US$0.3m after a string of quarterly losses. The market is trading the guidance trim and near term worries. The results...

Paycom Software went into this print with the stock already on a strong run, and then the market added a jolt. Shares jumped about 24% on the day after earnings, a sharp move for a payroll and human capital management software stock that many investors had tagged as a slower grower. The immediate trigger was not a flashy revenue surprise. The story was profit quality and efficiency. Adjusted EBITDA margin reached the mid 40s and free cash flow guidance for 2026 moved above US$650m. For a...

Gladstone Commercial opened the day on the front foot, with the stock up 5.5% to around $12.91 and adding to a steady 30 day climb. The short term message from the tape is simple: investors liked this earnings print. The headline is in the cash engine that matters for a real estate investment trust. Funds From Operations per share reached $0.38 in Q2 2026 while the quarterly dividend held at $0.30, which keeps the payout ratio under 80% on management’s figures. Revenue for the quarter came in...

TaskUs stock just ripped 24% higher to US$7.82, yet the real story sits in the cash generation and margins hiding behind that move. You are not just looking at a call center outsourcer catching a bid. You are looking at a customer experience and AI services company that delivered US$308.9m in Q2 revenue with adjusted EBITDA margin of 18.7% and enough adjusted free cash flow to lift the full year cash guide. The market traded the headline pop. The bigger question now is how durable this margin...

agilon health stock just dropped almost 20% in a single session, even though the headline from Q2 is a sharp swing back into positive unit economics. The company posted about US$1.5b in revenue and turned medical margin from a loss a year ago into roughly US$197m in Q2. That is the fulcrum for this earnings story. The market is fixated on the recent price volatility. The fundamentals this quarter are all about whether this jump in medical margin and US$70m of adjusted EBITDA can be...

STERIS stock has delivered an 11.4% total return over the past five years. At around US$231.78 per share it now screens as roughly in line with its Discounted Cash Flow (DCF) intrinsic value, while earnings-based multiples point to a richer price tag. For investors, the puzzle is that the DCF view suggests STERIS is fairly valued on cash flow assumptions, while the broader valuation checks and multiples imply the stock is not especially cheap. Over five years, STERIS has produced an 11.4%...

Clearway Energy stock jumped 5.4% to US$32.85 today, a sharp move for a utility style renewable operator that had been drifting over the past quarter. The spark was not a flashy revenue surprise. It was cold cash flow. Quarterly net income swung back into the black at US$122 million and cash available for distribution, or CAFD, landed at US$167 million. For short term traders that price pop may look like a quick win. For long term investors the more important story is how those CAFD and...

AI infrastructure stocks are back in the spotlight after a key AI computing enabler joined a high profile Bullpen watchlist, putting fresh attention on the companies that power artificial intelligence behind the scenes. That kind of focus can influence how money moves and which stocks investors discuss next. This article breaks down 3 stocks that appear closely tied to this news and explains why they might matter for your watchlist. The 3 AI infrastructure stocks covered below are just a...

In the second quarter of 2026, Liberty Broadband Corporation reported a net loss of US$2,125 million, reversing from net income of US$383 million a year earlier, with basic and diluted loss per share from continuing operations of US$14.86 versus earnings of US$2.49 previously. Over the first half of 2026, the company swung to a US$1,922 million net loss despite having previously completed a large, multi-year US$8,115.32 million share repurchase program that retired more than a third of its...

DHT Holdings stock barely flinched after earnings, up about 3% to US$18.35, yet the numbers behind that modest move were anything but quiet. You are looking at a crude tanker owner that just reported record quarterly results, with Q2 net income of US$198.3m and earnings of US$1.23 per share. Total revenue reached US$285.0m as very strong tanker spot rates flowed straight into the income statement. Over the past week the share price slipped slightly and the 3 month return is also down. The key...

Pattern Group stock closed at US$22.09, down 6.5% on the day, as investors reacted hard to a report that mixed solid sales with lingering loss fatigue. The headline this quarter is not revenue, which came in at US$876.8m, but the ongoing strain from losses that still hang over the trailing twelve months. Short term traders focused on the red ink and the recent slide in the share price. Long term holders will be weighing those losses against improving quarterly earnings per share and a...

Root came into this earnings print on a cold streak, with the stock already down over 20% across the past month. The latest Q2 numbers then triggered a fresh hit, with the share price falling more than 16% to US$50.51 by the close after the report. The market focused on a softer profit line, as basic earnings per share slipped to US$1.54 and net income came in at US$24.1 million. At the same time, investors had to weigh those figures against a still profitable underwriting engine, with the...

Insmed stock has surged over the past three years, yet the broader valuation checks currently point to a mixed picture rather than a clear bargain or clear overvaluation at the recent price of US$132.55. After a very sharp three year gain, investors are weighing that performance against valuation indicators that suggest the shares lean expensive on market multiples. Insmed has delivered a very large return of roughly 4.8x over the past three years, which puts extra focus on whether the...

The market just took a hard swing at Driven Brands Holdings, with the stock dropping about 11% to close near US$12.96. Yet the headline story from Q2 is not a collapse in the engine of the business. System wide sales reached about US$1.6b and revenue came in at roughly US$507m, with adjusted earnings before interest, tax, depreciation and amortization at US$107m. Today’s selloff looks like investors fixated on near term caution and restatement noise, while a steady, if unspectacular, earnings...

The market raced ahead of the story on Honest Company. The stock jumped about 41% in regular trading to US$5.42, building on already strong short term gains, after Q2 numbers landed. The headline is not about sales growth. It is about a sharp swing into profit and fatter margins in a business that had been losing money over the past year. Honest Company posted Q2 net income of US$10.7 million on US$83.3 million of revenue and reported gross margin of 48.4%. For a brand often viewed as a niche...

Legacy Housing stock jumped about 5% to US$28.90 after the Q2 print, but the real story sits beyond today’s bounce. You are looking at a manufacturer that just posted a record quarter, with net revenue of US$66.3m and net income of US$23.5m, while still trading on a P/E multiple below peers and the wider Consumer Durables sector. In the short term, the headline is simple: the market liked the quarter. The bigger question for investors is how long this level of profitability and discounted...

F&G Annuities & Life slipped about 1.6% to US$29.18 today, even though the headline from Q2 was not a revenue crack but an earnings air pocket. Reported basic earnings per share swung to a loss of US$0.62 and net income moved to a loss of US$81 million, as weaker alternative investment returns hit what is essentially a spread and fee income story. For a stock that still trades on a single digit P/E and has been edging higher over the past three months, the real question now is whether this...

IonQ stock barely flinched after earnings, slipping about 1% to US$39.67, even as the company reported what it called its strongest quarter yet. For a quantum computing stock that has fallen over the past one and three months, that muted move suggests investors are still processing what a headline revenue figure of US$80.1m and a US$1.9b quarterly loss really mean. The key story is the contrast between rapid top line growth and a very heavy loss line. Short term traders may focus on the loss...

Constellation Energy stock has pulled back this year after a strong three year run, yet the latest valuation work suggests the shares may still trade below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and supporting earnings multiples. Constellation Energy has delivered a 152.1% total return over the past three years, which puts recent share price weakness in the context of a much stronger longer term move. Growing demand for power infrastructure tied to AI and...

Central Garden & Pet stock rose 5.6% to US$46.54 today as investors reacted to a garden and pet supplies quarter that appeared stronger beneath the surface than the headline sales figure suggests. Reported net sales were US$882.4m, while non-GAAP operating margin reached 15.4%. Management also raised full-year non-GAAP earnings per share guidance to at least US$2.85. In the short term, this looks like a relief rally. Over a longer horizon, the key question is whether this margin progress and...